[EN] CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USE<br/>[FR] PROMÉDICAMENTS DE CARBIDOPA ET DE L-DOPA ET MÉTHODES D'UTILISATION
申请人:ABBVIE INC
公开号:WO2017184871A1
公开(公告)日:2017-10-26
The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease.